Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis

Abstract Background Recent trials suggested that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose co-transporter-2 (SGLT-2) inhibitors reduced cardiovascular events. Comparative effectiveness of these new antidiabetic drug classes remains unclear. We therefore performed a net...

Full description

Bibliographic Details
Main Authors: Yue Fei, Man-Fung Tsoi, Bernard Man Yung Cheung
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Cardiovascular Diabetology
Subjects:
Antidiabetic drug
Network meta-analysis
Type 2 diabetes mellitus
Cardiovascular outcome
Online Access:http://link.springer.com/article/10.1186/s12933-019-0916-z

Internet

http://link.springer.com/article/10.1186/s12933-019-0916-z

Similar Items